How Sleep Maintains Phosphoproteome Homeostasis?
Prolonged sleep deprivation (Pr-SD) is known to be lethal across many species. While several mechanisms linked to sleep regulation and the fatal consequences of sleep loss have been identified, the core molecular basis connecting Pr-SD lethality to sleep homeostasis in mammals has remained unclear.
Building on this, on June 24, 2025, Professor Zhiqiang Wang's research team from the School of Life Science and Technology, Harbin Institute of Technology, published a study in Cell Discovery titled: "Sleep prevents brain phosphoproteome disruption to safeguard survival." This research reveals that sleep prevents brain phosphoproteome disruption, thereby safeguarding survival.
Products
Creative Biolabs provides an extensive portfolio of products and services designed to advance neuroscience investigations. Please contact us for more information.
Cat. No | Product Name | Product Types |
---|---|---|
NCL2110P254 | Tau Phosphorylation Assay Cell Line | Cell line |
NAB201250LS | Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) | Antibodies |
NPP2011ZP291 | Phospho-ERK1/2 (T202/Y204 / T185/Y187) / Total In-Cell ELISA Kit | Kits |
NRZP-0722-ZP223 | Human phosphorylated microtubule-associated protein tau (pMAPT /pTAU) ELISA kit | Kits |
Services | Description |
---|---|
Tau Phosphorylation Assay Service | Understanding tau phosphorylation is crucial. Abnormal tau phosphorylation is a key hallmark in these devastating conditions, making its accurate measurement essential for drug discovery, biomarker identification, and mechanistic studies. |
Overview
A key phenomenon highlighted by classic research is that during prolonged sleep deprivation, individuals enter an irreversible "point of no return (PONE)" state.
In a recent study, researchers used a prolonged sleep deprivation model and a reliable method to predict this PONE state. They found that mice in the PONE state couldn't enter natural sleep and showed significant disruption in their brain's phosphoproteome (the complete set of phosphorylated proteins). This disruption wasn't just about how long they were awake; it was directly linked to being in the PONE state.
The study also revealed that abnormal function of kinases (enzymes that add phosphates to proteins) or phosphatases (enzymes that remove them) in the brain accelerated the development of the PONE state and led to corresponding sleep abnormalities.
Crucially, just 80 minutes of recovery sleep each day significantly delayed the onset of the PONE state and restored the brain's phosphoproteome to a normal state. By combining recovery sleep with compensatory phosphatase expression, the harmful effects of excessive kinase activity on PONE development could be eliminated.
In summary, this research indicates that sleep is essential for maintaining the stability of the brain's phosphoproteome. Disruptions to this stability may not only contribute to the lethality caused by prolonged sleep deprivation but also impact normal sleep regulation mechanisms.
Fig.1 Assessment of PONE status during prolonged sleep deprivation.1
Findings of the Study
This study reveals the crucial role of sleep in maintaining the stability of the brain's phosphoproteome, further clarifying, at a molecular level, sleep's protective function for survival and adaptation. The authors' findings may offer a new perspective on NREMS delta wave power and its potential representation of sleep homeostatic mechanisms, while also increasing our understanding of its importance.
Disclaimer: Please note that we do not provide the content above, nor do we hold copyright to it. This article is for informational and knowledge-sharing purposes only and does not constitute an offer of commercial services related to its subject matter.
Resources
Reference
- Ma, Jing et al. "Sleep prevents brain phosphoproteome disruption to safeguard survival." Cell discovery vol. 11,1 58. 24 Jun. 2025, doi:10.1038/s41421-025-00809-w. 7 Jun. 2025, doi:10.1038/s41386-025-02144-w. Distributed under Open Access license CC BY 4.0, without modification.

- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)